Faecal microbial biomarkers in early diagnosis of colorectal cancer. Issue 23 (9th November 2021)

• Record Type: Journal Article
• Authors: Olovo, Chinasa Valerie; Huang, Xinxiang; Zheng, Xueming; Xu, Min
• Is Part Of: Journal of cellular and molecular medicine. Volume 25:Issue 23(2021)
• Page Start: 10783
• Page End: 10797
• Publication Date: 2021-11-09
• Subjects: adenoma -- carcinoma -- colorectal cancer -- dysbiosis -- early diagnosis -- faecal microbiota; Cytology; Medicine; Molecular Biology; Cytologie -- Périodiques; Médecine -- Périodiques; Biologie moléculaire -- Périodiques; Cytology -- Periodicals; Medicine -- Periodicals; Molecular biology -- Periodicals; 611.01805
• DOI: 10.1111/jcmm.17010
• Languages: English
• ISSNs: 1582-1838

Abstract

Abstract: Colorectal cancer (CRC) is ranked as the second most common cause of cancer deaths and the third most common cancer globally. It has been described as a 'silent disease' which is often easily treatable if detected early—before progression to carcinoma. Colonoscopy, which is the gold standard for diagnosis is not only expensive but is also an invasive diagnostic procedure, thus, effective and non‐invasive diagnostic methods are urgently needed. Unfortunately, the current methods are not sensitive and specific enough in detecting adenomas and early colorectal neoplasia, hampering treatment and consequently, survival rates. Studies have shown that imbalances in such a relationship which renders the gut microbiota in a dysbiotic state are implicated in the development of adenomas ultimately resulting in CRC. The differences found in the makeup and diversity of the gut microbiota of healthy individuals relative to CRC patients have in recent times gained attention as potential biomarkers in early non‐invasive diagnosis of CRC, with promising sensitivity, specificity and even cost‐effectiveness. This review summarizes recent studies in the application of these microbiota biomarkers in early CRC diagnosis, limitations encountered in the area of the faecal microbiota studies as biomarkers for CRC, and future research exploits that address these limitations.